Global Gonorrhea Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 13-Jul-2021
No. of pages: 98
Inquire Before Buying

Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospects.

The latest trend gaining momentum in the market is Advent of vaccine for prevention of gonorrhea. Gonorrhea is a major public health concern globally. It is considerably affecting the reproductive health of people and increasing the spread of human immunodeficiency virus (HIV). The currently available treatment regimen is unsuccessful in controlling the spread of Neisseria gonorrhoeae due to the rapid emergence of the antibiotic-resistant strains of this bacterium. Therefore, the prevention of the disease seems to be a more appropriate approach for controlling the spread of Neisseria gonorrhoeae.

Market Analysis and Insights: Global Gonorrhea Therapeutics Market

The global Gonorrhea Therapeutics market size is projected to reach US$ 1427.7 million by 2027, from US$ 1052.4 million in 2020, at a CAGR of 4.0% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gonorrhea Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gonorrhea Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gonorrhea Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gonorrhea Therapeutics market.

Global Gonorrhea Therapeutics Scope and Market Size

Gonorrhea Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gonorrhea Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Monotherapy

- Dual Therapy

Segment by Application

- Clinics

- Hospitals

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Bharat Pharmaceuticals

- GlaxoSmithKline

- Merck

- Pfizer

- Alopexx Pharmaceuticals

- AstraZeneca

- Debiopharm Group

- Melinta Therapeutics

Global Gonorrhea Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gonorrhea Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Dual Therapy
1.3 Market by Application
1.3.1 Global Gonorrhea Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gonorrhea Therapeutics Market Perspective (2016-2027)
2.2 Gonorrhea Therapeutics Growth Trends by Regions
2.2.1 Gonorrhea Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gonorrhea Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Gonorrhea Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Gonorrhea Therapeutics Industry Dynamic
2.3.1 Gonorrhea Therapeutics Market Trends
2.3.2 Gonorrhea Therapeutics Market Drivers
2.3.3 Gonorrhea Therapeutics Market Challenges
2.3.4 Gonorrhea Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gonorrhea Therapeutics Players by Revenue
3.1.1 Global Top Gonorrhea Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Gonorrhea Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Gonorrhea Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gonorrhea Therapeutics Revenue
3.4 Global Gonorrhea Therapeutics Market Concentration Ratio
3.4.1 Global Gonorrhea Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gonorrhea Therapeutics Revenue in 2020
3.5 Gonorrhea Therapeutics Key Players Head office and Area Served
3.6 Key Players Gonorrhea Therapeutics Product Solution and Service
3.7 Date of Enter into Gonorrhea Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gonorrhea Therapeutics Breakdown Data by Type
4.1 Global Gonorrhea Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Gonorrhea Therapeutics Forecasted Market Size by Type (2022-2027)
5 Gonorrhea Therapeutics Breakdown Data by Application
5.1 Global Gonorrhea Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Gonorrhea Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gonorrhea Therapeutics Market Size (2016-2027)
6.2 North America Gonorrhea Therapeutics Market Size by Type
6.2.1 North America Gonorrhea Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Gonorrhea Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Gonorrhea Therapeutics Market Size by Type (2016-2027)
6.3 North America Gonorrhea Therapeutics Market Size by Application
6.3.1 North America Gonorrhea Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Gonorrhea Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Gonorrhea Therapeutics Market Size by Application (2016-2027)
6.4 North America Gonorrhea Therapeutics Market Size by Country
6.4.1 North America Gonorrhea Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Gonorrhea Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Gonorrhea Therapeutics Market Size (2016-2027)
7.2 Europe Gonorrhea Therapeutics Market Size by Type
7.2.1 Europe Gonorrhea Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Gonorrhea Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Gonorrhea Therapeutics Market Size by Type (2016-2027)
7.3 Europe Gonorrhea Therapeutics Market Size by Application
7.3.1 Europe Gonorrhea Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Gonorrhea Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Gonorrhea Therapeutics Market Size by Application (2016-2027)
7.4 Europe Gonorrhea Therapeutics Market Size by Country
7.4.1 Europe Gonorrhea Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Gonorrhea Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gonorrhea Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Type
8.2.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gonorrhea Therapeutics Market Size by Application
8.3.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gonorrhea Therapeutics Market Size by Region
8.4.1 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gonorrhea Therapeutics Market Size (2016-2027)
9.2 Latin America Gonorrhea Therapeutics Market Size by Type
9.2.1 Latin America Gonorrhea Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Gonorrhea Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Gonorrhea Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Gonorrhea Therapeutics Market Size by Application
9.3.1 Latin America Gonorrhea Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Gonorrhea Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Gonorrhea Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Gonorrhea Therapeutics Market Size by Country
9.4.1 Latin America Gonorrhea Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Gonorrhea Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gonorrhea Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Type
10.2.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gonorrhea Therapeutics Market Size by Application
10.3.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gonorrhea Therapeutics Market Size by Country
10.4.1 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bharat Pharmaceuticals
11.1.1 Bharat Pharmaceuticals Company Details
11.1.2 Bharat Pharmaceuticals Business Overview
11.1.3 Bharat Pharmaceuticals Gonorrhea Therapeutics Introduction
11.1.4 Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.1.5 Bharat Pharmaceuticals Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Gonorrhea Therapeutics Introduction
11.2.4 GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Gonorrhea Therapeutics Introduction
11.3.4 Merck Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gonorrhea Therapeutics Introduction
11.4.4 Pfizer Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Alopexx Pharmaceuticals
11.5.1 Alopexx Pharmaceuticals Company Details
11.5.2 Alopexx Pharmaceuticals Business Overview
11.5.3 Alopexx Pharmaceuticals Gonorrhea Therapeutics Introduction
11.5.4 Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.5.5 Alopexx Pharmaceuticals Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Gonorrhea Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Debiopharm Group
11.7.1 Debiopharm Group Company Details
11.7.2 Debiopharm Group Business Overview
11.7.3 Debiopharm Group Gonorrhea Therapeutics Introduction
11.7.4 Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.7.5 Debiopharm Group Recent Development
11.8 Melinta Therapeutics
11.8.1 Melinta Therapeutics Company Details
11.8.2 Melinta Therapeutics Business Overview
11.8.3 Melinta Therapeutics Gonorrhea Therapeutics Introduction
11.8.4 Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2016-2021)
11.8.5 Melinta Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Gonorrhea Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Dual Therapy
Table 4. Global Gonorrhea Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gonorrhea Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gonorrhea Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gonorrhea Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Gonorrhea Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gonorrhea Therapeutics Market Share by Regions (2022-2027)
Table 10. Gonorrhea Therapeutics Market Trends
Table 11. Gonorrhea Therapeutics Market Drivers
Table 12. Gonorrhea Therapeutics Market Challenges
Table 13. Gonorrhea Therapeutics Market Restraints
Table 14. Global Gonorrhea Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gonorrhea Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonorrhea Therapeutics as of 2020)
Table 17. Ranking of Global Top Gonorrhea Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gonorrhea Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gonorrhea Therapeutics Product Solution and Service
Table 21. Date of Enter into Gonorrhea Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gonorrhea Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Gonorrhea Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gonorrhea Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gonorrhea Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gonorrhea Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Gonorrhea Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gonorrhea Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gonorrhea Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gonorrhea Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gonorrhea Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gonorrhea Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gonorrhea Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gonorrhea Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gonorrhea Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gonorrhea Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gonorrhea Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gonorrhea Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bharat Pharmaceuticals Company Details
Table 62. Bharat Pharmaceuticals Business Overview
Table 63. Bharat Pharmaceuticals Gonorrhea Therapeutics Product
Table 64. Bharat Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Bharat Pharmaceuticals Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Gonorrhea Therapeutics Product
Table 69. GlaxoSmithKline Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Gonorrhea Therapeutics Product
Table 74. Merck Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Gonorrhea Therapeutics Product
Table 79. Pfizer Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Alopexx Pharmaceuticals Company Details
Table 82. Alopexx Pharmaceuticals Business Overview
Table 83. Alopexx Pharmaceuticals Gonorrhea Therapeutics Product
Table 84. Alopexx Pharmaceuticals Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Alopexx Pharmaceuticals Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Gonorrhea Therapeutics Product
Table 89. AstraZeneca Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. Debiopharm Group Company Details
Table 92. Debiopharm Group Business Overview
Table 93. Debiopharm Group Gonorrhea Therapeutics Product
Table 94. Debiopharm Group Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Debiopharm Group Recent Development
Table 96. Melinta Therapeutics Company Details
Table 97. Melinta Therapeutics Business Overview
Table 98. Melinta Therapeutics Revenue in Gonorrhea Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Melinta Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gonorrhea Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Dual Therapy Features
Figure 4. Global Gonorrhea Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Clinics Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. Gonorrhea Therapeutics Report Years Considered
Figure 9. Global Gonorrhea Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Gonorrhea Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Gonorrhea Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Gonorrhea Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Gonorrhea Therapeutics Market Share by Players in 2020
Figure 14. Global Top Gonorrhea Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gonorrhea Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Gonorrhea Therapeutics Revenue in 2020
Figure 16. Global Gonorrhea Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Gonorrhea Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Gonorrhea Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Gonorrhea Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Gonorrhea Therapeutics Market Share by Region (2016-2027)
Figure 38. China Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Gonorrhea Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Gonorrhea Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Gonorrhea Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Gonorrhea Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Gonorrhea Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bharat Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 61. Alopexx Pharmaceuticals Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 63. Debiopharm Group Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 64. Melinta Therapeutics Revenue Growth Rate in Gonorrhea Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
  • Global Sexually Transmitted Diseases Testing Professional Survey Report 2023, Forecast to 2028
    Published: 22-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sexually Transmitted Diseases Testing Market Research Report 2023, Forecast to 2028
    Published: 22-Dec-2023        Price: US 2680 Onwards        Pages: 130
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sexually Transmitted Disease (STD) Testing Market Status and Outlook 2023-2028
    Published: 23-Nov-2023        Price: US 3160 Onwards        Pages: 102
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sexually Transmitted Disease (Std) Testing Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Oct-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Sexually Transmitted Disease (Std) Testing market: According to our latest research, the global Sexually Transmitted Disease (Std) Testing market looks promising in the next 5 years. As of 2022, the global Sexually Transmitted Disease (Std) Testing market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and pr......
  • Global Gonorrhea Therapeutics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Oct-2023        Price: US 3380 Onwards        Pages: 98
    Market Overview of Global Gonorrhea Therapeutics market: According to our latest research, the global Gonorrhea Therapeutics market looks promising in the next 5 years. As of 2022, the global Gonorrhea Therapeutics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Gonorrhea is a sexually transmitted disease (STD) caused by the bacterium Neisseria gonorrhea. It tends to infect the urethra......
  • Global Gonorrhea Therapeutics Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 89
    Gonorrhea is a sexually transmitted disease (STD) that affects both men and women. The infection affects the genitals, rectum, and the throat. The treatment landscape typically involves the use of antibiotics with dual therapy dominating the market compared with monotherapy. As the market has a deep penetration of generics, the growth rate is expected to be moderate during the forecast period. Additionally, the advent of new antibiotic-resistant strains will continue to hinder the growth prospec......
  • Global Sexually Transmitted Disease (STD) Testing Market Insights, Forecast to 2029
    Published: 01-Jun-2023        Price: US 4900 Onwards        Pages: 92
    Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD). Market Analysis and Insights: Global Sexually Transmitted Disease (STD) Testing Market The global Sexually Transmitted Disease (STD) Testing market is projected to grow from US$ 225.3 million in 2023 to US$ 338.1 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period. The need for tests that eliminate ......
  • Global Sexually Transmitted Disease (STD) Testing Market Research Report 2023
    Published: 05-May-2023        Price: US 2900 Onwards        Pages: 89
    Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD). Highlights The global Sexually Transmitted Disease (STD) Testing market was valued at US$ 225.3 million in 2022 and is anticipated to reach US$ 338.1 million by 2029, witnessing a CAGR of 7.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. The need ......
  • Global Gonorrhea Therapeutics Market Status and Outlook 2023-2028
    Published: 24-Apr-2023        Price: US 3160 Onwards        Pages: 104
    Neisseria gonorrhoeae infection can manifest as a variety of symptoms, which can affect the genitourinary system, anorectum, pharynx, and conjunctival area. Severe cases can lead to disseminated gonococcal infection, endocarditis and meningitis; in women, it is pelvic inflammatory disease (PID). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs